Jason A Hoffman

Title: Jason A. Hoffman: Innovator in Cardiovascular Therapeutics

Introduction

Jason A. Hoffman is a prominent inventor based in La Jolla, California. He has made significant contributions to the field of cardiovascular therapeutics, holding a total of 6 patents. His work focuses on the development of peptides that selectively target heart vasculature, which has important implications for treating various cardiovascular diseases.

Latest Patents

One of Jason A. Hoffman's latest patents involves peptides that selectively home to heart vasculature and related conjugates and methods. This invention provides a variety of isolated peptides and peptidomimetics that can be utilized in constructing conjugates or as therapeutic agents for cardiovascular diseases. The patent details isolated peptides or peptidomimetics with lengths of less than 60 residues, including specific amino acid sequences such as CRPPR, CARPAR, and CPKRPR. These innovations represent a significant advancement in the therapeutic landscape for cardiovascular health.

Career Highlights

Throughout his career, Jason A. Hoffman has worked with esteemed institutions such as the Burnham Institute for Medical Research and the Sanford-Burnham Medical Research Institute. His research has focused on the intersection of peptide technology and cardiovascular medicine, leading to groundbreaking discoveries that enhance treatment options for patients.

Collaborations

Jason has collaborated with notable scientists in his field, including Erkki I. Ruoslahti and Lianglin Zhang. These partnerships have fostered a collaborative environment that has propelled advancements in cardiovascular research.

Conclusion

Jason A. Hoffman is a key figure in the development of innovative therapies for cardiovascular diseases. His contributions through patents and collaborations continue to shape the future of medical research and treatment.